Clinical Trials Search Results

Search for

in

Accepting Participants (1)

Showing 1-1 of 1

Sorted By:

A-Z
Z-A

Previous Next

M15-954 (Verona): A Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)
Venetoclax is an investigational drug being developed for the treatment of MDS. 2 treatment arms: venetoclax and AZA or AZA and placebo. Enroll newly diagnosed higher-risk MDS

Previous Next

© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.